指南与共识呼吸道感染

老年社区获得性肺炎指南一致性抗生素治疗与1年全因及心血管死亡率的关联

Guideline-Concordant Antibiotic Therapy for the Hospital Treatment of Community-Acquired Pneumonia and 1-Year All-Cause and Cardiovascular Mortality in Older Adult Patients Surviving to Discharge.
指南 / 共识 · Chest · 2023-01-05

本研究纳入2004至2015年间在加拿大渥太华医院因社区获得性肺炎(CAP)住院并存活出院的1909例年龄>65岁患者,分析初始抗生素治疗与现行临床实践指南的一致性是否与出院后1年全因及心血管死亡率相关。结果显示,指南一致性抗生素治疗与1年全因死亡率降低呈趋势相关(HR 0.82;95%CI 0.65-1.04;95%CI 0.34-0.80;

要点

  • 老年CAP住院存活患者中,指南一致性抗生素治疗与1年心血管死亡风险显著降低相关(HR 0.53)。
  • 该发现进一步支持现行CAP临床实践指南推荐的初始抗生素选择。

核心结论

  • 老年CAP住院患者使用指南一致性抗生素治疗与1年心血管死亡风险显著降低近50%相关。
  • 指南一致性抗生素治疗与1年全因死亡率降低呈趋势相关,但差异未达统计学显著性。

研究设计与样本

  • 回顾性队列研究,纳入2004至2015年间加拿大渥太华医院因CAP住院并存活出院的1909例年龄>65岁患者。
  • 将患者信息链接至医院和省数据集,分析初始抗生素治疗与现行临床实践指南的一致性。
  • 对患者1年预期死亡风险、CAP严重程度及既往肺炎住院、心肌梗死、心力衰竭或脑血管病史进行调整。

临床怎么用

  • 对老年CAP住院患者,初始经验性抗生素选择应遵循现行临床实践指南,以可能降低远期心血管死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Selection of empiric antibiotic treatment for community-acquired pneumonia (CAP) that is concordant with clinical practice guidelines has been associated with improved short-term outcomes of this infection, but whether it is also associated with longer-term outcomes is unknown. RESEARCH QUESTION: Is guideline-concordance of the initial antibiotic treatment given to older adult patients hospitalized with CAP associated with the 1-year all-cause and cardiovascular mortality risk of those patients who survive hospitalization for this infection? STUDY DESIGN AND METHODS: A total of 1,909 older (> 65 years of age) patients were identified who survived hospitalization for CAP at The Ottawa Hospital (Ontario, Canada) between 2004 and 2015. Linking patients' information to hospital and provincial data sets, this study analyzed whether the selection of the initial antibiotic therapy for their CAP was concordant with current clinical practice guidelines, and whether guideline-concordance was associated with 1-year all-cause and cardiovascular mortality following their index CAP hospitalization. Adjustments were made for the patients' overall 1-year expected death risk; CAP severity; and history of previous pneumonia admissions, myocardial infarction, heart failure, or cerebrovascular disease. RESULTS: Selection of guideline-concordant antibiotic therapy was associated with a trend towards lower all-cause mortality at 1 year post-CAP (hazard ratio, 0.82; 95% CI, 0.65-1.04; P = .099). Furthermore, the use of guideline-concordant antibiotic therapy was associated with a significant almost 50% reduction in cardiovascular death risk 1 year following CAP admission (hazard ratio, 0.53; 95% CI, 0.34-0.80; P = .003). INTERPRETATION: Use of guideline-concordant antibiotic therapy for CAP treatment in older hospitalized patients is associated with a significant reduction in the risk of cardiovascular death at 1 year post-CAP. This finding further supports current clinical practice guideline recommendations for CAP treatment.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Corrales-Medina, van Walraven. Guideline-Concordant Antibiotic Therapy for the Hospital Treatment of Community-Acquired Pneumonia and 1-Year All-Cause and Cardiovascular Mortality in Older Adult Patients Surviving to Discharge. Chest. 2023. PMID: 36621760. doi:10.1016/j.chest.2022.12.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。